HITTechnology · Software - ApplicationThe 2 Wall Street analysts covering Health In Tech, Inc. hold a median 12-month price target of $4 — +496.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 11 of 100 as at 13 Oct 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Health In Tech, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (82): Smaller than most of the companies we track.
Momentum (6): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on HIT, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +496.3% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 14 Aug 2026 | Maxim Group | Maintains | Buy | $4.00 → $3.00 |
| 20 Apr 2026 | Craig-Hallum | Initiates | Buy | $4.00 |
| 20 Apr 2026 | Craig-Hallum | Initiates | Buy | — |
| 26 June 2025 | Maxim Group | Initiates | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HIT appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, Health In Tech, Inc. returned −80.8% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 9% of US stocks
Cheaper than 62% of US stocks
Cheaper than 39% of US stocks
Cheaper than 21% of US stocks
Higher than 13% of US stocks
Higher than 24% of US stocks
Higher than 60% of US stocks
Higher than 18% of US stocks
Higher than 19% of US stocks
Higher than 31% of US stocks
Higher than 24% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Health In Tech, Inc. has a market value of $43.8M and an enterprise value of $40.9M.
Revenue in the twelve months to 30 June 2026: $32.8M. The latest quarter shrank 13.5% year on year.
Net income over the same four quarters: −$3.9M, a −12.0% net margin.
Diluted earnings per share, trailing twelve months: $−0.07.
Free cash flow in the twelve months to 30 June 2026: −$7.6M.
Trailing P/E: 76.0×; forward P/E: −33.9× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Health In Tech, Inc. employs 87 people — $377K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Health In Tech, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Health In Tech launched HitRix, a broker-first environment for self-funded stop-loss placement. It combines submission intake, market routing, quote comparison and case tracking in one coordinated process.
Why it matters — HIT watchers may note the launch as a new marketplace offering focused on streamlining the stop-loss placement process for brokers.
Health In Tech, Inc. (Nasdaq: HIT) announced that representatives from its management and investor relations teams will attend the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026, at the Sheraton New York Times Square Hotel in New York City.
Why it matters — The conference participation provides HIT with an opportunity to present its AI-enabled InsurTech platform to investors and industry participants.
Health In Tech, Inc. announced the launch of HitRix, an AI-powered platform designed to modernize the U.S. self-funded health insurance market by streamlining large-group submissions, multi-market quoting, proposal comparison, and placement in a secure environment. The company also announced updated full-year 2026 revenue guidance.
Why it matters — A HIT watcher would care because the new HitRix platform expands the company's product offerings into the large self-funded insurance market while the updated 2026 revenue guidance signals a change in the company's forward outlook.
Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company, announced it has been named to Newsweek's America's Greatest Mid-Market Companies 2026. The recognition followed an initial review of approximately 4,300 companies, with HIT among the 100 highest-scoring U.S. public mid-market companies based on financial strength, workforce performance, innovation and sustainability.
Why it matters — This award offers external validation of HIT's financial strength, workforce performance, innovation and sustainability, which could raise the company's visibility among investors and customers.
Health In Tech, Inc. (HIT) held its Q2 2026 earnings call, and Seeking Alpha published the full transcript of the call. The transcript documents the company's second-quarter fiscal 2026 results and related management discussion.
Why it matters — A HIT watcher would note the earnings call transcript as a primary source of the company's latest quarterly financial performance and management commentary.
The 2 Wall Street analysts covering Health In Tech, Inc. have a median 12-month price target of $4, with estimates ranging from $1.25 to $4.1. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 2 analysts covering Health In Tech, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Health In Tech, Inc. 11 out of 100 across roughly 4,600 US stocks as at 13 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Oct 2026, Health In Tech, Inc. ranks 11 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (82 of 100).
No one can know that. What the data says: the median 12-month target from 2 analysts implies +496.3% from the last close, and Ticker Nerd's factor model ranks Health In Tech, Inc. 11 out of 100 as at 13 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Health In Tech, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HIT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.25 to $4.1 over the next 12 months.
Health In Tech, Inc. returned -80.8% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Health In Tech Inc. Class A Common Stock represents the public equity of Health In Tech Inc., an insurance technology platform company focused on the healthcare and insurance ecosystem.
The most recent item we track (PRNewsWire, 8 Oct 2026): "Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement". Health In Tech launched HitRix, a broker-first environment for self-funded stop-loss placement. It combines submission intake, market routing, quote comparison and case tracking in one coordinated process.
Health In Tech Inc. Class A Common Stock represents the public equity of Health In Tech Inc., an insurance technology platform company focused on the healthcare and insurance ecosystem. Health In Tech provides a marketplace designed to simplify underwriting, sales, and service workflows through vertical integration, process automation, and AI-enabled tools. Its current offerings include group insurance captives, community health plans, association health programs, self-funded benefits administration, stop-loss underwriting support, web-based quoting software, and services that help manage medical records, claims, and provider network pricing. The company serves small and medium-sized employers, licensed brokers, insurance companies, and third-party administrators, positioning itself as a technology layer that streamlines core insurance operations. Health In Tech Inc. is headquartered in Stuart, Florida.
CEO Mr. Tim Johnson · 87 employees · United States · https://healthintech.com
